Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for MIRM

Stock Name	Mirum Pharmaceuticals Inc
Ticker	MIRM(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US6047491013

Show aggregate MIRM holdings

News associated with MIRM

Brokerages Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Target Price at $74.44: Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) has been assigned a consensus recommendation of “Buy” from the nine ratings firms that are covering the stock, Marketbeat reports. Eight research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average twelve-month target price […] - 2025-09-19 02:26:46
Mirum Pharmaceuticals (NASDAQ:MIRM) Lowered to Buy Rating by Wall Street Zen: Wall Street Zen lowered shares of Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) from a strong-buy rating to a buy rating in a research note released on Monday morning. Other analysts have also recently issued research reports about the stock. Raymond James Financial reissued a “strong-buy” rating on shares of Mirum Pharmaceuticals in a research note […] - 2025-08-26 03:03:11
Wall Street Zen Upgrades Mirum Pharmaceuticals (NASDAQ:MIRM) to Strong-Buy: Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Sunday. A number of other equities analysts also recently weighed in on the stock. JMP Securities set a $81.00 target price […] - 2025-08-19 02:58:52
Deutsche Bank AG Buys 71,421 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM): Deutsche Bank AG grew its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 42.2% during the first quarter, Holdings Channel reports. The firm owned 240,744 shares of the company’s stock after purchasing an additional 71,421 shares during the period. Deutsche Bank AG’s holdings in Mirum Pharmaceuticals were worth $10,846,000 as of its most […] - 2025-08-15 05:22:53
Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Rating Upgraded by Wall Street Zen: Wall Street Zen upgraded shares of Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) from a hold rating to a buy rating in a research report released on Saturday morning. Several other research analysts have also commented on the stock. HC Wainwright raised their price objective on shares of Mirum Pharmaceuticals from $73.00 to $80.00 and gave […] - 2025-08-12 04:48:59
Mirum Pharmaceuticals (NASDAQ:MIRM) Shares Up 9.1% on Analyst Upgrade: Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) were up 9.1% during trading on Monday after Wall Street Zen upgraded the stock from a hold rating to a buy rating. The stock traded as high as $65.31 and last traded at $65.41. Approximately 671,423 shares traded hands during mid-day trading, an increase of […] - 2025-08-12 02:18:51
Zurcher Kantonalbank Zurich Cantonalbank Boosts Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM): Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 3.8% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 10,998 shares of the company’s stock after purchasing an additional 398 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Mirum Pharmaceuticals were worth $495,000 […] - 2025-08-08 04:48:50
Cwm LLC Boosts Stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM): Cwm LLC boosted its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 259.4% during the first quarter, HoldingsChannel reports. The institutional investor owned 593 shares of the company’s stock after buying an additional 428 shares during the quarter. Cwm LLC’s holdings in Mirum Pharmaceuticals were worth $27,000 at the end of the most […] - 2025-08-06 04:24:52
Bank of New York Mellon Corp Buys 122,402 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM): Bank of New York Mellon Corp boosted its position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 98.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 246,730 shares of the company’s stock after purchasing an additional 122,402 shares during the […] - 2025-07-21 04:26:48
Allspring Global Investments Holdings LLC Sells 1,195 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM): Allspring Global Investments Holdings LLC cut its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 12.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,786 shares of the company’s stock after selling 1,195 shares during the period. Allspring […] - 2025-07-11 04:36:57
KBC Group NV Makes New $89,000 Investment in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM): KBC Group NV acquired a new position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 1,967 shares of the company’s stock, valued at approximately $89,000. Other hedge funds have also added to or […] - 2025-07-08 04:42:53
Mirum Pharmaceuticals (NASDAQ:MIRM) Lowered to Hold Rating by Wall Street Zen: Wall Street Zen downgraded shares of Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) from a buy rating to a hold rating in a research note published on Sunday morning. MIRM has been the topic of a number of other reports. HC Wainwright reiterated a “buy” rating and set a $73.00 price objective on shares of Mirum […] - 2025-07-07 03:22:59
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives $60.73 Consensus Target Price from Analysts: Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) has earned a consensus recommendation of “Buy” from the twelve ratings firms that are presently covering the company, MarketBeat reports. Ten equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average twelve-month price […] - 2025-06-11 02:22:45
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 16.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 73,888 shares of the company’s stock after acquiring an additional […] - 2025-06-06 04:42:48
ProShare Advisors LLC Grows Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM): ProShare Advisors LLC grew its stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 31.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,457 shares of the company’s stock after acquiring an additional 3,227 shares during […] - 2025-05-26 06:09:07
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $1.01 Million Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM): MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lowered its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 2.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 24,327 shares of the company’s stock after selling 498 shares during the quarter. MIRAE […] - 2025-05-26 04:38:55
Nuveen Asset Management LLC Has $29.86 Million Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM): Nuveen Asset Management LLC boosted its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 46.7% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 722,155 shares of the company’s stock after buying an additional 229,746 shares during the quarter. Nuveen Asset Management LLC’s holdings in Mirum Pharmaceuticals were worth $29,861,000 as of […] - 2025-05-22 06:38:53
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Bought by Millennium Management LLC: Millennium Management LLC grew its holdings in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 15.7% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 526,974 shares of the company’s stock after acquiring an additional 71,410 shares during the quarter. Millennium Management LLC owned about 1.10% […] - 2025-05-21 05:46:51
HC Wainwright Reiterates Buy Rating for Mirum Pharmaceuticals (NASDAQ:MIRM): Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a research note issued to investors on Monday, Marketbeat.com reports. They currently have a $73.00 price objective on the stock. HC Wainwright’s price objective points to a potential upside of 61.01% from the company’s current price. […] - 2025-05-21 03:03:17
Comerica Bank Decreases Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM): Comerica Bank lessened its holdings in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 76.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 617 shares of the company’s stock after selling 1,971 shares during the period. Comerica Bank’s […] - 2025-05-20 04:28:52
Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) PT at $58.20: Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) have been given an average recommendation of “Buy” by the eleven ratings firms that are covering the stock, Marketbeat reports. Ten research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12 […] - 2025-04-22 02:34:59
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives $58.20 Consensus Target Price from Analysts: Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) have earned a consensus rating of “Buy” from the eleven research firms that are presently covering the firm, MarketBeat reports. Ten analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year price […] - 2025-03-28 03:34:46
AlphaQuest LLC Grows Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM): AlphaQuest LLC increased its position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 969.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,829 shares of the company’s stock after acquiring an additional 1,658 shares during the quarter. AlphaQuest LLC’s holdings in […] - 2025-03-20 06:04:50
Bank of New York Mellon Corp Has $5.14 Million Stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM): Bank of New York Mellon Corp grew its holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 8.4% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 124,328 shares of the company’s stock after acquiring an additional 9,629 shares during the period. Bank of New York Mellon Corp’s holdings in Mirum Pharmaceuticals were […] - 2025-03-18 05:09:03
Empowered Funds LLC Invests $1.38 Million in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM): Empowered Funds LLC acquired a new stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 33,266 shares of the company’s stock, valued at approximately $1,376,000. A number of other large investors […] - 2025-02-17 06:16:48
Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Price Target at $57.10: Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) have received a consensus rating of “Buy” from the eleven ratings firms that are presently covering the company, MarketBeat reports. Ten equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average […] - 2025-02-06 04:24:49

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) MIRM holdings

Date	Number of MIRM Shares Held	Base Market Value of MIRM Shares	Local Market Value of MIRM Shares	Change in MIRM Shares Held	Change in MIRM Base Value	Current Price per MIRM Share Held	Previous Price per MIRM Share Held
2025-11-11 (Tuesday)	32,719	USD 2,333,519	USD 2,333,519	0	USD 52,678	USD 71.32	USD 69.71
2025-11-10 (Monday)	32,719	USD 2,280,841	USD 2,280,841	84	USD 58,071	USD 69.71	USD 68.11
2025-11-07 (Friday)	32,635	USD 2,222,770	USD 2,222,770	0	USD 12,728	USD 68.11	USD 67.72
2025-11-06 (Thursday)	32,635	USD 2,210,042	USD 2,210,042	84	USD -71,458	USD 67.72	USD 70.09
2025-11-05 (Wednesday)	32,551	USD 2,281,500	USD 2,281,500	0	USD -28,644	USD 70.09	USD 70.97
2025-11-04 (Tuesday)	32,551	USD 2,310,144	USD 2,310,144	84	USD 9,857	USD 70.97	USD 70.85
2025-11-03 (Monday)	32,467	USD 2,300,287	USD 2,300,287	0	USD -58,441	USD 70.85	USD 72.65
2025-10-31 (Friday)	32,467	USD 2,358,728	USD 2,358,728	0	USD 14,611	USD 72.65	USD 72.2
2025-10-30 (Thursday)	32,467	USD 2,344,117	USD 2,344,117	420	USD 86,085	USD 72.2	USD 70.46
2025-10-29 (Wednesday)	32,047	USD 2,258,032	USD 2,258,032	168	USD 10,244	USD 70.46	USD 70.51
2025-10-28 (Tuesday)	31,879	USD 2,247,788	USD 2,247,788	0	USD -34,111	USD 70.51	USD 71.58
2025-10-27 (Monday)	31,879	USD 2,281,899	USD 2,281,899	0	USD 49,731	USD 71.58	USD 70.02

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MIRM by Blackrock for IE00BDZVHG35

Show aggregate share trades of MIRM

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-10 BUY 84 71.200 67.443 67.819 USD 5,697 49.57
2025-11-06 BUY 84 70.330 67.425 67.716 USD 5,688 49.37
2025-11-04 BUY 84 72.620 69.745 70.033 USD 5,883 49.14
2025-10-30 BUY 420 72.390 69.830 70.086 USD 29,436 48.76
2025-10-29 BUY 168 70.460 71.860 71.720 USD 12,049 48.64
2025-10-22 SELL -336 69.600 70.450 70.365 USD -23,643 48.02 Loss of -7,510 on sale
2025-10-20 BUY 168 73.030 74.330 74.200 USD 12,466 47.75
2025-10-17 BUY 420 73.530 74.550 74.448 USD 31,268 47.59
2025-10-15 BUY 672 76.190 76.405 76.383 USD 51,330 47.43
2025-10-03 BUY 581 72.950 73.260 73.229 USD 42,546 47.12
2025-10-02 BUY 83 71.750 72.980 72.857 USD 6,047 46.97
2025-09-30 BUY 166 73.310 74.728 74.586 USD 12,381 46.65
2025-09-26 BUY 166 72.760 74.520 74.344 USD 12,341 46.33
2025-09-25 BUY 166 73.570 74.540 74.443 USD 12,358 46.16
2025-09-18 BUY 86 75.320 75.340 75.338 USD 6,479 45.98
2025-09-17 BUY 258 73.140 74.030 73.941 USD 19,077 45.80
2025-07-17 SELL -172 52.730 53.190 53.144 USD -9,141 45.50 Loss of -1,315 on sale
2025-07-16 BUY 520 52.800 53.590 53.511 USD 27,826 45.45
2025-07-11 SELL -680 52.660 53.910 53.785 USD -36,574 45.31 Loss of -5,763 on sale
2025-07-02 BUY 4,675 49.090 49.330 49.306 USD 230,506 45.14
2025-06-25 BUY 170 50.130 51.050 50.958 USD 8,663 44.99
2025-06-20 BUY 840 50.340 51.280 51.186 USD 42,996 44.87
2025-06-11 BUY 164 48.460 49.180 49.108 USD 8,054 44.60
2025-06-10 BUY 164 48.980 50.050 49.943 USD 8,191 44.57
2025-06-04 SELL -82 44.610 45.740 45.627 USD -3,741 44.53 Loss of -90 on sale
2025-04-23 BUY 82 39.620 40.140 40.088 USD 3,287 44.79
2025-04-10 SELL -656 39.120 41.225 41.014 USD -26,906 45.37 Profit of 2,856 on sale
2025-04-08 SELL -82 39.320 43.160 42.776 USD -3,508 45.48 Profit of 222 on sale
2025-04-07 SELL -82 41.000 43.220 42.998 USD -3,526 45.54 Profit of 208 on sale
2025-04-04 SELL -410 42.030 43.033 42.933 USD -17,602 45.58 Profit of 1,084 on sale
2025-04-01 BUY 844 44.040 45.520 45.372 USD 38,294 45.60
2025-03-31 SELL -240 45.050 45.710 45.644 USD -10,955 45.61 Loss of -9 on sale
2025-03-21 BUY 1,535 47.020 48.491 48.344 USD 74,208 45.53
2025-03-14 SELL -1,216 44.280 45.900 45.738 USD -55,617 45.52 Loss of -269 on sale
2025-03-07 SELL -150 43.460 44.240 44.162 USD -6,624 45.63 Profit of 220 on sale
2025-03-04 SELL -75 45.220 46.090 46.003 USD -3,450 45.69 Loss of -24 on sale
2025-02-25 BUY 150 49.930 51.740 51.559 USD 7,734 45.47
2025-02-19 SELL -75 52.170 53.755 53.597 USD -4,020 44.97 Loss of -647 on sale
2025-02-13 BUY 225 50.700 51.825 51.713 USD 11,635 44.50
2025-02-12 BUY 75 50.720 51.000 50.972 USD 3,823 44.38
2025-02-11 BUY 300 50.160 50.780 50.718 USD 15,215 44.25
2024-12-30 SELL -2,393 41.180 41.970 41.891 USD -100,245 42.37 Profit of 1,135 on sale
2024-11-18 SELL -1,215 41.420 44.390 44.093 USD -53,573 40.00 Loss of -4,976 on sale
2024-11-08 SELL -81 42.000 42.575 42.518 USD -3,444 39.69 Loss of -229 on sale
2024-10-21 SELL -82 39.350 39.490 39.476 USD -3,237 0.00 Loss of -3,237 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	84	71.200	67.443	67.819	USD 5,697	49.57
2025-11-06	BUY	84	70.330	67.425	67.716	USD 5,688	49.37
2025-11-04	BUY	84	72.620	69.745	70.033	USD 5,883	49.14
2025-10-30	BUY	420	72.390	69.830	70.086	USD 29,436	48.76
2025-10-29	BUY	168	70.460	71.860	71.720	USD 12,049	48.64
2025-10-22	SELL	-336	69.600	70.450	70.365	USD -23,643	48.02 Loss of -7,510 on sale
2025-10-20	BUY	168	73.030	74.330	74.200	USD 12,466	47.75
2025-10-17	BUY	420	73.530	74.550	74.448	USD 31,268	47.59
2025-10-15	BUY	672	76.190	76.405	76.383	USD 51,330	47.43
2025-10-03	BUY	581	72.950	73.260	73.229	USD 42,546	47.12
2025-10-02	BUY	83	71.750	72.980	72.857	USD 6,047	46.97
2025-09-30	BUY	166	73.310	74.728	74.586	USD 12,381	46.65
2025-09-26	BUY	166	72.760	74.520	74.344	USD 12,341	46.33
2025-09-25	BUY	166	73.570	74.540	74.443	USD 12,358	46.16
2025-09-18	BUY	86	75.320	75.340	75.338	USD 6,479	45.98
2025-09-17	BUY	258	73.140	74.030	73.941	USD 19,077	45.80
2025-07-17	SELL	-172	52.730	53.190	53.144	USD -9,141	45.50 Loss of -1,315 on sale
2025-07-16	BUY	520	52.800	53.590	53.511	USD 27,826	45.45
2025-07-11	SELL	-680	52.660	53.910	53.785	USD -36,574	45.31 Loss of -5,763 on sale
2025-07-02	BUY	4,675	49.090	49.330	49.306	USD 230,506	45.14
2025-06-25	BUY	170	50.130	51.050	50.958	USD 8,663	44.99
2025-06-20	BUY	840	50.340	51.280	51.186	USD 42,996	44.87
2025-06-11	BUY	164	48.460	49.180	49.108	USD 8,054	44.60
2025-06-10	BUY	164	48.980	50.050	49.943	USD 8,191	44.57
2025-06-04	SELL	-82	44.610	45.740	45.627	USD -3,741	44.53 Loss of -90 on sale
2025-04-23	BUY	82	39.620	40.140	40.088	USD 3,287	44.79
2025-04-10	SELL	-656	39.120	41.225	41.014	USD -26,906	45.37 Profit of 2,856 on sale
2025-04-08	SELL	-82	39.320	43.160	42.776	USD -3,508	45.48 Profit of 222 on sale
2025-04-07	SELL	-82	41.000	43.220	42.998	USD -3,526	45.54 Profit of 208 on sale
2025-04-04	SELL	-410	42.030	43.033	42.933	USD -17,602	45.58 Profit of 1,084 on sale
2025-04-01	BUY	844	44.040	45.520	45.372	USD 38,294	45.60
2025-03-31	SELL	-240	45.050	45.710	45.644	USD -10,955	45.61 Loss of -9 on sale
2025-03-21	BUY	1,535	47.020	48.491	48.344	USD 74,208	45.53
2025-03-14	SELL	-1,216	44.280	45.900	45.738	USD -55,617	45.52 Loss of -269 on sale
2025-03-07	SELL	-150	43.460	44.240	44.162	USD -6,624	45.63 Profit of 220 on sale
2025-03-04	SELL	-75	45.220	46.090	46.003	USD -3,450	45.69 Loss of -24 on sale
2025-02-25	BUY	150	49.930	51.740	51.559	USD 7,734	45.47
2025-02-19	SELL	-75	52.170	53.755	53.597	USD -4,020	44.97 Loss of -647 on sale
2025-02-13	BUY	225	50.700	51.825	51.713	USD 11,635	44.50
2025-02-12	BUY	75	50.720	51.000	50.972	USD 3,823	44.38
2025-02-11	BUY	300	50.160	50.780	50.718	USD 15,215	44.25
2024-12-30	SELL	-2,393	41.180	41.970	41.891	USD -100,245	42.37 Profit of 1,135 on sale
2024-11-18	SELL	-1,215	41.420	44.390	44.093	USD -53,573	40.00 Loss of -4,976 on sale
2024-11-08	SELL	-81	42.000	42.575	42.518	USD -3,444	39.69 Loss of -229 on sale
2024-10-21	SELL	-82	39.350	39.490	39.476	USD -3,237	0.00 Loss of -3,237 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MIRM

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	72,234	12,268	239,583	30.1%
2025-09-18	56,289	4,189	270,196	20.8%
2025-09-17	63,196	2,072	246,781	25.6%
2025-09-16	51,643	737	135,386	38.1%
2025-09-15	64,888	1,194	154,251	42.1%
2025-09-12	57,160	4,688	134,198	42.6%
2025-09-11	70,286	15,334	174,511	40.3%
2025-09-10	82,464	5,085	167,281	49.3%
2025-09-09	73,988	834	336,086	22.0%
2025-09-08	97,340	13,009	164,656	59.1%
2025-09-05	80,692	16,260	182,480	44.2%
2025-09-04	78,856	4,815	267,458	29.5%
2025-09-03	107,413	6,645	236,559	45.4%
2025-09-02	93,337	13,124	262,898	35.5%
2025-08-29	121,904	48,466	300,335	40.6%
2025-08-28	1,070,514	487,947	1,261,346	84.9%
2025-08-27	178,887	15,088	336,545	53.2%
2025-08-26	162,362	47,309	392,103	41.4%
2025-08-25	152,416	11,814	376,254	40.5%
2025-08-22	239,539	18,239	501,022	47.8%
2025-08-21	102,778	1,810	220,353	46.6%
2025-08-20	65,999	15,860	117,614	56.1%
2025-08-19	109,840	23,102	254,294	43.2%
2025-08-18	143,781	13,657	280,969	51.2%
2025-08-15	143,436	7,364	448,893	32.0%
2025-08-14	135,036	152	253,879	53.2%
2025-08-13	142,034	13,145	401,031	35.4%
2025-08-12	204,950	18,158	529,102	38.7%
2025-08-11	547,438	66,339	931,938	58.7%
2025-08-08	130,750	16,423	382,752	34.2%
2025-08-07	516,882	25,348	928,076	55.7%
2025-08-06	128,256	184	252,662	50.8%
2025-08-05	78,055	14	157,095	49.7%
2025-08-04	43,796	60	120,847	36.2%
2025-08-01	52,940	79	107,267	49.4%
2025-07-31	55,097	0	107,016	51.5%
2025-07-30	43,200	0	115,799	37.3%
2025-07-29	68,753	0	113,923	60.4%
2025-07-28	36,200	19	54,133	66.9%
2025-07-25	58,369	8	87,772	66.5%
2025-07-24	65,168	33	94,132	69.2%
2025-07-23	135,117	183	188,922	71.5%
2025-07-22	76,666	0	101,231	75.7%
2025-07-21	61,211	389	96,968	63.1%
2025-07-18	28,143	0	61,650	45.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE